NC-STAT dpn neurometrix test

Fast, accurate and quantitative test that may be used to evaluate peripheral neuropathies such as diabetic peripheral neuropathy (DPN)

· Quantitative results - measures sural nerve conduction velocity and response amplitude - standard biomarkers for asymptomatic and clinical peripheral neuropathies
· Sensitive and specific for peripheral neuropathies including (DPN)7-8, and predictive of its complications8
· Accurate technology - based on the established and validated NC-stat® Technology1-6
· Straightforward clinical interpretation
· Compact and ergonomic hand-held device designed for ease-of-use
· Single patient use biosensors
· Cost effective testing

CLINICAL BENEFITS

Patient management can be positively impacted with DPNCheck by detecting, confirming, and monitoring peripheral neuropathies.

DPNCheck is particularly useful in the evaluation and management of patients with diabetic peripheral neuropathy (DPN):

· Early detection of DPN, even in the absence of symptoms and signs
· Help confirm or rule-out DPN and quantify severity
· Monitor changes in DPN over time and in response to treatmen
· Early diagnosis of DPN presents opportunities to intervene and reduce costs
· Identify those patients with neuropathy that are at highest risk for neuropathy related complications such as foot ulcers, neuropathic pain, and falls
· DPN related ulcers and amputations have 5 year mortality rates comparable to colon cancer and worse than other common cancers, click here to view mortality data.

RESULTS

Clinical interpretation is straightforward with clearly defined normal limits (>4 microvolts & >40 meters per second). An interpretation guide is supplied with the device.

Optional PC software is available that provides the following:

· Hard copy or PDF report with waveforms and results
· Automatic comparison to normal limits and identification of longitudinal changes
· Data archiving
· EMR connectivity